| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/07/2004 | EP1377591A1 Tumour inhibiting gallium compounds |
| 01/07/2004 | EP1377589A1 Oxazolyl-pyrazole derivatives as kinase inhibitors |
| 01/07/2004 | EP1377588A1 4-beta-1''-[(2''-(substituted benzoyl)anilino] podophyllotoxin analogues useful as anticancer agents |
| 01/07/2004 | EP1377587A1 Protein phosphate inhibitors |
| 01/07/2004 | EP1377579A2 Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents |
| 01/07/2004 | EP1377578A1 Beta-carboline derivatives and its pharmaceutical use against depression and anxiety |
| 01/07/2004 | EP1377576A2 Pyridine derivatives |
| 01/07/2004 | EP1377573A2 Pyrazolopyridine derivatives |
| 01/07/2004 | EP1377572A1 Isoxaxole derivatives as inhibitors of src and other protein kinases |
| 01/07/2004 | EP1377571A1 Compounds for use in the treatment of skin conditions |
| 01/07/2004 | EP1377569A1 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines with adenosine receptor-binding activity and their use as cardiovascular preparations |
| 01/07/2004 | EP1377559A2 Rxr activating molecules |
| 01/07/2004 | EP1377552A1 Metal complexes and therapeutic uses thereof |
| 01/07/2004 | EP1377551A1 Antiproliferative agents |
| 01/07/2004 | EP1377540A1 INHIBITORS OF INTEGRIN AvB6 |
| 01/07/2004 | EP1377320A2 Polynucleotide binding complexes comprising sterols and saponins |
| 01/07/2004 | EP1377319A2 Fusion proteins |
| 01/07/2004 | EP1377301A2 Normalization of defective t cell responsiveness through manipulation of thymic regeneration |
| 01/07/2004 | EP1377295A2 Carboxamide derivatives as therapeutic agents |
| 01/07/2004 | EP1377291A2 1-butyric acid derivatives such as carbomethoxypropionyl cyanide or leflunomide derivatives, and the therapeutic use thereof |
| 01/07/2004 | EP1377290A2 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 01/07/2004 | EP1377287A2 Proanthocyanidins for the treatment of amyloid and alpha-synuclein diseases |
| 01/07/2004 | EP1377282A2 Aryl-n-cyanoguanidines and methods related thereto |
| 01/07/2004 | EP1377281A1 Taurine compounds |
| 01/07/2004 | EP1377276A2 Timed pulse release composition |
| 01/07/2004 | EP1377251A2 A cell therapy method for the treatment of tumors |
| 01/07/2004 | EP1377220A1 Fluorescent cobalamins and uses thereof |
| 01/07/2004 | EP1377213A1 Method of predicting stroke evolution utilising mri |
| 01/07/2004 | EP1377164A1 Erythropoietin ameliorates chemotherapy-induced toxicity in vivo |
| 01/07/2004 | EP1294388B1 Extracts from sophora species, method for producing the same and their use |
| 01/07/2004 | EP1098643B1 Phenylacetylglutamine, phenylacetylisoglutamine, and/or phenylacetate for the treatment of neoplastic diseases |
| 01/07/2004 | EP1019082B1 Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 01/07/2004 | EP0931092B1 Variants of vascular endothelial cell growth factor having antagonistic properties |
| 01/07/2004 | EP0647270B1 Novel malignant cell type markers of the interior nuclear matrix |
| 01/07/2004 | EP0600880B1 Interleukin 1- beta protease and interleukin 1-beta protease inhibitors |
| 01/07/2004 | CN1466680A Improved anti-viral and anti-tumor chemotherapy by administration of erythropoeitin |
| 01/07/2004 | CN1466625A Method of proliferating natural killer cells |
| 01/07/2004 | CN1466594A Polysaccharides with antithrombotic activity comprising at least a covalent bono with biotin or a biotin derivative |
| 01/07/2004 | CN1466592A 17a-fluoroalkyl steroids method for producing the same and pharmaceutical compositions containing said compounds |
| 01/07/2004 | CN1466591A Nucleoside derivatives |
| 01/07/2004 | CN1466580A Thiazole or oxazole derivatives |
| 01/07/2004 | CN1466467A Pharmaceutical composition and method for treating hypogonadism |
| 01/07/2004 | CN1466464A Novel remedies for cancer |
| 01/07/2004 | CN1466462A Method for producing agrimonia extract with improved activity against hepatitis Bvirus and pharmaceutical and flood compositions containing said extract |
| 01/07/2004 | CN1466458A Use of arginine in the preparation of a medicament for the prevention and treatment of the side effcts associated with the intravenous administration |
| 01/07/2004 | CN1466451A Ion-strength independent sustained release pharmacetuical formulation |
| 01/07/2004 | CN1465704A Cancer suppressor gene PINX1 and use thereof |
| 01/07/2004 | CN1465701A Novel ribozyme of specificity cutting survivin, its medicinal composition and use |
| 01/07/2004 | CN1465696A Polypeptide-trorsine 14 and polynucleotide for coding said polypeptide |
| 01/07/2004 | CN1465583A 8-chloro-adenosine analogs, compositions containing said compound and use thereof |
| 01/07/2004 | CN1465582A Nucleotide analogs, medicinal compositions having same and use thereof |
| 01/07/2004 | CN1465570A Process for preparing genistein, medicinal composition and use thereof |
| 01/07/2004 | CN1465401A Process for preparing acellular short corynebacteria preparation |
| 01/07/2004 | CN1465400A Preparation and application for human carcino-embryonic antigen and cell differentiation antigen 40 ligand fused tumor vaccine |
| 01/07/2004 | CN1465396A Anti-tumor medicine |
| 01/07/2004 | CN1465394A Medicine for treating oophoritic cyst and its preparation process |
| 01/07/2004 | CN1465387A Chinese medicine preparation for treating carcinoma of esophagus |
| 01/07/2004 | CN1465353A Becterin of Serratia marcescens for curing |
| 01/07/2004 | CN1465351A Crocodile immunization anti-cancer pill |
| 01/07/2004 | CN1465350A Toad skin preparation and productive process thereof |
| 01/07/2004 | CN1465348A Compound ablation mixture and application in preparing medicine for treating tumor |
| 01/07/2004 | CN1133654C Carboxynethylated derivative of ganoderic alpha-(1-3)-D-glucosan and its usage and preparing process |
| 01/07/2004 | CN1133653C Ganoderic alpha-(1-3)-D-glucosan sulfate derivative and its usage and preparing process |
| 01/07/2004 | CN1133648C Substituted phenylalamine type compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 01/07/2004 | CN1133647C Heterocyclic compound used as leucocyte adherence inhibitor and VLA-4 antagonist |
| 01/07/2004 | CN1133645C Antineoplastic compound intercedenside A |
| 01/07/2004 | CN1133642C Nucleoside 5'-thiophosphoryl amino-acid ester compound |
| 01/07/2004 | CN1133641C Thiophosphamino acid ester compound containing 3'-azido-deoxythymidine and its preparation process |
| 01/07/2004 | CN1133640C 3'-azido-deoxythymidine-5'-thiopyhosphamino acid ester compound and its preparing process |
| 01/07/2004 | CN1133635C Cyanopyrroles as progesterone receptor agonists |
| 01/07/2004 | CN1133625C Quinazoline derivatives |
| 01/07/2004 | CN1133621C Cyclohexanediole derivatives |
| 01/07/2004 | CN1133464C Pharmaceutical compositions for controlled release of soluble receptors |
| 01/07/2004 | CN1133440C Stomach and kidney disease treating medicine powder |
| 01/07/2004 | CN1133436C Ultrasonic concentration-difference acid-alkali method for preparing doxorubicin hydrochloride lipid as injection |
| 01/07/2004 | CN1133434C Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| 01/07/2004 | CN1133430C Release-controlling coating of antineoplastic leurocristine |
| 01/07/2004 | CN1133424C Repamycin formulations for oral administration |
| 01/06/2004 | US6673927 Farnesyl transferase inhibitors |
| 01/06/2004 | US6673903 Antiproliferative agents |
| 01/06/2004 | US6673897 Inhibitors of NF-κB Activation |
| 01/06/2004 | US6673895 Pro-apoptotic fragments of the dengue virus envelope glycoproteins |
| 01/06/2004 | US6673839 L-acetylcarnitine and somatostatin |
| 01/06/2004 | US6673833 As antitumor agent |
| 01/06/2004 | US6673825 Urazole compounds useful as anti-inflammatory agents |
| 01/06/2004 | US6673809 Tricyclic compounds as MRP1-inhibitors |
| 01/06/2004 | US6673805 Platinum derivative pharmaceutical formulations |
| 01/06/2004 | US6673803 Quinazoline derivatives and pharmaceutical compositions containing them |
| 01/06/2004 | US6673798 PDGF receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same |
| 01/06/2004 | US6673796 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 01/06/2004 | US6673789 2-pyridinylguanidine urokinase inhibitors |
| 01/06/2004 | US6673787 Pyrimidinesulfonamide containing indole compounds used as antiangiogenic and antitumor agents |
| 01/06/2004 | US6673780 Such as 4-(4-(3-hydroxy-3-methyl-butane-1-sulfinylmethyl)-phenylmethanesulfinyl)-2 -methyl-butan1-ol for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders |
| 01/06/2004 | US6673611 Nucleic acid molecules with novel chemical compositions capable of modulating gene expression |
| 01/06/2004 | US6673573 Expression of immunoglobulin-cytokine fusion proteins in malignant B cells |
| 01/06/2004 | US6673564 Detecting modulators of polypeptide activity in cell; obtain cell, incubate with modulator, monitor cellular activity and compare to control |
| 01/06/2004 | US6673379 Use of non-alkalized cocoa solids in a drink |
| 01/06/2004 | US6673375 Mostly comprising sodium metasilicate (pentahydrate) and shows nonspecific immunostimulating activity in plants and animals |
| 01/06/2004 | US6673370 Oxidized collagen formulations for use with non-compatible pharmaceutical agents |
| 01/06/2004 | CA2301990C New substitute dimerized derivatives, process for preparing them, and pharmaceutical compounds containing them |